Assistant Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
|1999||University of Louisville School of Medicine, Louisville, KY, USA, MD, Medicine|
|1995||University of Kentucky, Lexington, KY, USA, BS, Chemical Engineering|
- Arnold SM, Rinehart JJ, Tsakalozou E, Eckardt JR, Fields SZ, Shelton BJ, DeSimone PA, Kee BK, Moscow JA, Leggas M. A phase I study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin in adult patients with refractory or metastatic solid malignancies. Clin Cancer Res 16(2):673-80, 2010. e-Pub 2010. PMID: 20068096.
- George B, You Y, Viswanathan, Wen S, Baladandayuthapani V, Overman MJ, Kee, BK, Kopetz S, Eng C, Garrett CR. Survival advantage associated with palliative oophorectomy in patietnts with metastatic colorectal cancer (CRC) to the ovaries (mCRC-0): a single institution retrospective analysis. J Clin Oncol 29(Suppl 4), 2011.
- Leggas M, Horn J, Tsakalozou E, Moscow JA, Fields SZ, Houchins JC, Eckardt JR, DeSimone P, Kee BK, Rinehart JJ, Arnold SM. Pharmacokinetics (PK) of the highly lipophilic and blood stable camptothecin AR-67 (7-t-butyldimethylsily1-10-hydroxycamptothecin) in adult patients with solid malignancies. J Clin Oncol 27:15S, 2009.
- Arnold SM, Horn J, Eckardt JR, Rinehart JJ, DeSimone P, Fields SZ, Kee BK, Moscow JA, Houchins JC, Leggas M. Clinical and pharmacokinetic (PK) findings in a phase I study of 7-t-butyldimethylsily1-10-hydroxycamptothecin (AR-67) in patients with refractory solid tumors. J Clin Oncol 27:15S, 2009.